文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

COPD急性加重的中性粒细胞性、嗜酸性粒细胞性和混合型表型的临床特征

Clinical characteristics of neutrophilic, eosinophilic and mixed-type exacerbation phenotypes of COPD.
PubMed 文献 · Am J Emerg Med · 2020-08-18
一句话结论急诊COPD急性加重中,中性粒细胞型表型者临床表现更重,3个月内死亡率38.9%,高于嗜酸性粒细胞型19.2%和混合型19.4%。

该前瞻性队列研究纳入147例急诊就诊的COPD急性加重患者,按血液表型分为中性粒细胞型(90例,61.2%)、嗜酸性粒细胞型(26例,17.7%)和混合型(31例,21.1%)。中性粒细胞型患者年龄更大、更常出现心动过速和血氧饱和度下降、痰量更多。3个月内死亡35例(38.9%)见于中性粒细胞型,嗜酸性粒细胞型死亡5例(19.2%),混合型死亡6例(19.4%)(p=.044)。三组间住院率和ICU入住率无差异。提示急诊COPD急性加重中性粒细胞型表型临床表现更重,可能影响死亡率。

要点

  • 急诊COPD急性加重患者中,中性粒细胞型占61.2%(90/147),嗜酸性粒细胞型占17.7%(26/147),混合型占21.1%(31/147)。
  • 中性粒细胞型患者较嗜酸性粒细胞型年龄更大、更常心动过速和血氧饱和度下降、痰量更多。
  • 3个月内死亡率:中性粒细胞型38.9%(35/90) vs 嗜酸性粒细胞型19.2%(5/26) vs 混合型19.4%(6/31),p=.044。
  • 三组间住院率和ICU入住率无差异。
  • 急诊COPD急性加重中性粒细胞型表型临床表现更重,可能影响死亡率。

适用人群与场景

  • 急诊就诊的COPD急性加重患者,前瞻性队列纳入147例(共评估173例)。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 前瞻性队列研究,最终分析147例急诊COPD急性加重患者,分为中性粒细胞型(90例,61.2%)、嗜酸性粒细胞型(26例,17.7%)和混合型(31例,21.1%)。
  • 中性粒细胞型较嗜酸性粒细胞型年龄更大、更常心动过速和血氧饱和度下降、痰量更多。
  • 3个月内死亡率:中性粒细胞型38.9%(35/90) vs 嗜酸性粒细胞型19.2%(5/26) vs 混合型19.4%(6/31),p=.044。
  • 三组间住院率和ICU入住率无差异。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 原文未述证据等级或推荐强度。
  • 原文未述局限性。

对床旁实践的改变

  • 急诊COPD急性加重患者可依据血液表型分类,中性粒细胞型表型者临床表现更重、死亡率更高,可能有助于床旁风险分层。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Chronic obstructive pulmonary disease (COPD) comprises a significant number of emergency department (ED) presentations, and hematological phenotypes may have prognostic significance. The aim of this study was to investigate the effect of hematological phenotypes on serious outcomes in COPD exacerbations.

METHODS: A prospective cohort study was carried out in patients with COPD exacerbation presenting to the ED. The patients were classified into three groups, including neutrophilic, eosinophilic, and mixed-type (including neutrophilic and eosinophilic features) COPD exacerbation. Outcome measures were defined as mortality, hospitalization, and need for intensive care unit (ICU) care within three months, and these outcomes were compared among groups.

RESULTS: A total of 173 COPD patients were assessed for eligibility, and 147 of them were included in the final analysis. The study population consisted of 90 patients with neutrophilic exacerbation (61.2%), 26 patients with eosinophilic exacerbation (17.7%), and 31 patients with mixed-type exacerbation (21.1%). The neutrophilic exacerbation group was older, was more often tachycardic and desaturated, and had more sputum production compared with the eosinophilic exacerbation group. Mortality was seen in 35 patients in the neutrophilic exacerbation group (38.9%), whereas 5 patients in the eosinophilic group (19.2%) and 6 patients in the mixed-type group (19.4%) died (p = .044). No difference was observed among groups in terms of hospital and ICU admission.

CONCLUSION: COPD exacerbations with neutrophilic phenotypes presented to the ED with more serious clinical findings compared with eosinophilic exacerbations. This may also have a possible effect on mortality.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Kandemir Y, Doğan NÖ, Yaka E, et al. Clinical characteristics of neutrophilic, eosinophilic and mixed-type exacerbation phenotypes of COPD. Am J Emerg Med. 2020. PMID: 33041140. doi:10.1016/j.ajem.2020.08.044

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。